Biotech company researchers are now trying to devise second-generation antibodies that send stronger signals to the immune system, in hopes that far more cancer patients will benefit.

FORBES: Magazine Article

In the case of Dr Forrest's Artificial Immune System, however, the analogy with biology is far stronger.

ECONOMIST: A thousand ills require a thousand cures